GCC Universe · Company profile

Lupin GCC in India

Lupin is listed in GCC Universe under Pharmaceuticals, Healthcare & Life Sciences. Its recorded India locations are Mumbai, Pune, and Bengaluru.

Last researched:

Company overview

Sector
Pharmaceuticals, Healthcare & Life Sciences
Sub-sector
Pharmaceuticals
Mandate (derived)
Sales, Marketing & BD
Parent headquarters
Mumbai, Maharashtra, India
Parent revenue (USD)
$3,000,000,000
Parent headcount
7,011
India headcount
Not disclosed

GCC locations

  • Mumbai
  • Pune
  • Bengaluru

Department mix

Global department counts, used as a proxy for the India mandate. These are not India team counts.

Sales
1,759
Operations
1,451
Marketing
1,421
Engineering
1,028
Information Technology
279
Business Development
271
Human Resources
183
Finance
174
Legal
135
Product Management
82
Administrative
72
Support
49
Accounting
40
Consulting
21
Education
13
Media And Commmunication
13
Data Science
10
Arts And Design
8
Entrepreneurship
2

Technology stack

  • .NET
  • 24-7 Media
  • ABB Distributed Control Systems (DCS)
  • AC500 PLC
  • ADP Workforce Now
  • AMP
  • ANGEL LMS
  • AT&T
  • AVEVA InTouch HMI
  • AVEVA PDMS
  • AWS Application Load Balancer
  • AWS VPC Lattice
  • Act!
  • Activa
  • Affiliate Window

Public leadership

Arnabi Marjit

Vice President Human Resources

Public leadership listed in the dataset; the role is not necessarily the India GCC head.

Research overview

Lupin Limited is an India-headquartered multinational pharmaceutical company founded in 1968 by Dr. Desh Bandhu Gupta, based in Mumbai. Consolidated Q3 FY2026 sales of INR 71,005 million (~USD 350 million, +26.4% YoY), with India ~29% of global sales, US ~44%. Global workforce over 24,000 across 15 manufacturing sites and 7 research centers; ranked No. 1 globally in pharma in the S&P Global Corporate Sustainability Assessment 2025.

India launch
1968
Maturity
Mature / Integrated Corporate Function

No distinct GCC, shared-services, or captive-center entity was found for Lupin in India. As an India-headquartered pharma major, its Mumbai/Pune/Bengaluru presence operates as an integrated part of the parent corporate structure rather than a delivery center serving a foreign parent.

Timeline

  1. 1968

    Lupin founded by Dr. Desh Bandhu Gupta, headquartered in Mumbai.

  2. 2026-02-26

    Lupin ranked No. 1 globally in pharma and top across all sectors in India in the S&P Global Corporate Sustainability Assessment 2025.

  3. 2026-03-17

    Lupin and Zydus Lifesciences signed a licensing agreement for Lupin to co-market an innovative semaglutide injection in India.

Leadership context

Arnabi Marjit is Vice President, Human Resources at Lupin, a role held since around 2012 after earlier serving as Head HR. Prior experience includes Head HR roles at REHAU and Kimberly-Clark, began career as a Manager at Tata Motors in 1996. Holds a BS in Economics (University of Calcutta), MS in Economics (Presidency College), and an Executive MBA in HR from SPJIMR (2003-2005). Based in Pune, India.

Hiring signal

Open roles
96
As of
2026-08-25
  • Manager - Product (Mumbai/Santacruz)
  • Sales Training (Mumbai/Santacruz)
  • Treasury Executive (Mumbai/Santacruz)
  • Manager - Production (Pune)
  • Research Associate (Pune)

News and developments

Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India

Partnership to co-market semaglutide injection using Lupin's domestic sales/marketing reach.

2026-03-17 Lupin ↗

Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025

ESG ranking achievement.

2026-02-26 Lupin ↗

Lupin Q3 FY2026 Results

Quarterly financial results.

2026-02-12 Lupin ↗

Sources

Sources and research notes

Source: Indian GCC 2026 Master Compendium, Company Master and research records. Sector, mandate and public leadership are derived fields. Missing values are shown as not disclosed. Revenue and global headcount describe the parent company, not the India centre.